Feedback / Questions
CUE-401 - Cue Biopharma
https://www.globenewswire.com/news-release/2025/06/24/3104701/0/en/Cue-Biopharma-Receives-FDA-Feedback-on-Pre-IND-Briefing-Document-Reinforcing-Company-s-Intention-to-Advance-IND-Submission-for-CUE-401-to-Address-Unmet-Need-in-the-Treatment-of-Aut.html
Jun 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next